| (210) | Number of the EPO application | 19739766 |
| (220) | Filing date of the EPO application | 2019.06.14 |
| (80) | EPO patent specification publication (B) | EPB nr. 23/2023, 2023.06.07 |
| (110) | EPO patent number | 3810201 |
| (11) | Number of the document | MD 3810201 T2 |
| (21) | Number of the application | e 2021 0405 |
| (71) | Name(s) of applicant(s), code of the country | ELI LILLY AND COMPANY, US; |
| (72) | Name(s) of inventor(s), code of the country | CORVARI Vincent John, US;
MINIE Christopher Sears, US;
MISHRA Dinesh Shyandeo, US;
QIAN Ken Kangyi, US; |
| (73) | Name(s) of owner(s), code of the country | ELI LILLY AND COMPANY, US; |
| (54) | Title of the invention | GIP/GLP1 agonist compositions |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 47/02 (2006.01.01); A61K 47/10 (2017.01.01); A61K 38/26 (2006.01.01); A61P 3/10 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2021.05.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2023.11.30 |
| (30) | Priority | 201862688632 P, 2018.06.22, US |
| (74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2019/037146, 2019.06.14 |
| (87) | International publication | WO 2019/245893, 2019.12.26 |